ClinicalTrials.Veeva

Menu
Life Clinical Research | Ipswich, Australia logo

Life Clinical Research | Ipswich, Australia

Research site

Site insights

Top conditions

Top treatments

Vicadrostat
LY3502970
BI 690517
Orforglipron
Baxdrostat
Empagliflozin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Paul Christensen | Site Director

Verified by this site

Active trials

3 of 3 total trials

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

The purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiova...

Begins enrollment this month
Chronic Kidney Disease
Atherosclerosis Cardiovascular Disease
Drug: Orforglipron
Drug: Placebo

The purpose of this study is to measure the efficacy and safety of baxdrostat in participants with uHTN or rHTN. The main objective is to compare the...

Active, not recruiting
Resistant Hypertension
Uncontrolled Hypertension
Drug: Placebo
Drug: Baxdrostat

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these cond...

Enrolling
Hypertension
Cardiovascular Diseases
Drug: Placebo matching Vicadrostat
Drug: Vicadrostat

Trial sponsors

AstraZeneca logo
Boehringer Ingelheim logo
Lilly logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems